Thalidomide Versus Bortezomib in Melphalan Refractory Myeloma

Clinical trial NCT00602511 · COMPLETED

Trial details

NCT number: NCT00602511
Sponsor: Nordic Myeloma Study Group
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Multiple Myeloma

Start date: 2007-10-01
Primary completion: 2010-09-01
Enrollment: 300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.